Jump to ContentJump to Main Navigation
A Decade of HAARTThe Development and Global Impact of Highly Active Antiretroviral Therapy$
Users without a subscription are not able to see the full content.

José M. Zuniga, Alan Whiteside, Amin Ghaziani, and John G. Bartlett

Print publication date: 2008

Print ISBN-13: 9780199225859

Published to Oxford Scholarship Online: September 2009

DOI: 10.1093/acprof:oso/9780199225859.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (oxford.universitypressscholarship.com). (c) Copyright Oxford University Press, 2021. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in OSO for personal use. date: 22 September 2021

The OPTIMA Cohort

The OPTIMA Cohort

(p.219) Chapter 15 The OPTIMA Cohort
A Decade of HAART

Mark Holodniy

Oxford University Press

This chapter reviews the Options in Management with Antiretrovirals (OPTIMA) study. OPTIMA study is the first tri-national collaboration between the US Department of Veterans Affairs (VA), Canadian Institutes for Health Research, and the UK Medical Research Council. It is a prospective, randomized, 2-factorial design study looking at the clinical utility of a three-month antiretroviral drug-free period (ARDFP), and whether there is a difference in effectiveness between standard and ‘mega-regimens’ (five or more active antiretroviral drugs).

Keywords:   highly active antiretroviral therapy, cohort study, Options in Management with Antiretrovirals, HIV/AIDS research

Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .